India, July 22 -- Rubicon Research Ltd has acquired its first manufacturing facility in the United States through its wholly owned subsidiary, AdvaGen Holdings, by purchasing a plant in East Brunswick, New Jersey, from InvaTech Pharma Solutions LLC for an enterprise value of USD 2.9 million.
As part of the transaction, completed on July 21, 2026, Rubicon has taken over the facility, including its lease, equipment, records and regulatory permits. The acquisition provides the company with a US manufacturing footprint comparable in size to its Satara facility in India, although it does not include any product approvals or regulatory filings.
The facility manufactures oral solid and oral liquid formulations and has undergone three successful ...